Skip to content

Safety and efficacy assessment of Synskin triple action eye contour cream

Safety and efficacy assessment of Synskin triple action eye contour cream (invisible) for reducing periorbital wrinkle, dark circle and puffiness

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210130050179N1
Enrollment
20
Registered
2021-02-20
Start date
2021-02-14
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periorbital wrinkle, dark circle and puffiness.

Interventions

Intervention group: Using Synskin triple action eye contour cream twice a day for 8 weeks.

Sponsors

Iran Avandfar Company
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Male or female aged 30-60 years The presence of periorbital wrinkle, dark circle and puffiness No change in life style during the study Signed informed consent knowingly

Exclusion criteria

Exclusion criteria: Critical untreated systemic disease in medical history Any facial rejuvenation treatment, including treatment with topical or oral products or supplements during the last four weeks Any facial rejuvenation treatment including rejuvenation devices or surgical procedures and Botox injections during the last four months Sensitivity and allergy to the components of the formulation Use of any eye cream or eye sunscreen cream during the last four weeks Use of anti-wrinkle or brightening cleansers over the past four weeks Pregnancy or lactation

Design outcomes

Primary

MeasureTime frame
Assessment of periorbital wrinkle, dark circle and puffiness by three independent physician using 0-3 scale. Timepoint: Before intervention and 4 and 8 weeks after treatment. Method of measurement: Three independent dermatologists perform evaluation and scoring with the help of right and left lateral view and full face photos based on the percentage of improvement in periorbital wrinkles, dark circle and puffiness using scale 0 to 3 (0 = no improvement 1 = relative improvement 2 = good improvement 3 = Excellent improvement) .

Secondary

MeasureTime frame
Area, volume and depth of periorbital wrinkle. Timepoint: Before intervention and 4 and 8 weeks after treatment. Method of measurement: Visioface.;Periorbital dark circle grading using Characteristics of Dark circles grade. Timepoint: Before intervention and 4 and 8 weeks after treatment. Method of measurement: Research physician will perform clinical assessments according to the Characteristics of Dark circles grade.;Melanin content. Timepoint: Before intervention and 4 and 8 weeks after treatment. Method of measurement: Mexameter.;Stratum corneum hydration. Timepoint: Before intervention and 4 and 8 weeks after treatment. Method of measurement: Corneometer.;Trans epidermal water loss. Timepoint: Before intervention and 4 and 8 weeks after treatment. Method of measurement: Tewameter.;Erythema. Timepoint: Before intervention and 4 and 8 weeks after treatment. Method of measurement: Mexameter.;Fitzpatrick’s Classification of Facial Wrinkling & degree of Elastosis. Timepoint: Before intervention and 4 and 8 weeks after treatment. Method of measurement: Research physician will perform clinical assessments according to the Fitzpatrick’s Classification.;Infra-orbital pigmentation severity and degree of lightness. Timepoint: Before intervention and 4 and 8 weeks after treatment. Method of measurement: Visioface.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTaraneh yazdanparast

Tehran University of Medical Sciences

drtaraneh@yahoo.com+98 21 8896 0880

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026